Showing results (111-120 of 263) with videos related to

Sort By:
Pageof 27
Research Square|September 18, 2023
The canonical HPA axis facilitates and maintains light adaptive behaviorHan Lee, Soaleha Shams, Viet Ha Dang Thi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2023
Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic reviewZsuzsanna Iyizoba-Ebozue, Robin Prestwich, Sarah Brown, et al.
Australian Health Review : a Publication of the Australian Hospital Association|January 27, 2025
The impact of COVID-19 on public and private emergency departments in Queensland, AustraliaAmy L Sweeny, Emma Hall, Anthony Padowitz, et al.
Emergency Medicine Australasia : EMA|June 4, 2026
Identifying Symptom Clusters Predictive of Acute Myocardial Infarction for Aboriginal and Torres Strait Islander and Non-Indigenous AustraliansJaimi Greenslade, William Parsonage, Laura Stephensen, et al.
European Urology Open Science|July 13, 2023
Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled TrialGe Yu, Stephen Rice, Rakesh Heer, et al.
The Lancet. Oncology|February 2, 2025
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical TreatmentShaista Hafeez, Fiona McDonald, Susan Lalondrelle, et al.
Oncogene|June 9, 2004
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcomeChristopher S Foster, Alison Falconer, Andrew R Dodson, et al.
European Radiology|August 24, 2023
The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastasesRicardo Donners, Nina Tunariu, Holly Tovey, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2024
Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancerAmanda Webster, Michael Francis, Hannah Gribble, et al.
Pageof 27